5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed. 5-Amino-1MQ is not fda-approved. available as research chemical. not scheduled or controlled.
What Does the Research Say About 5-Amino-1MQ?
Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Research interest has focused on its potential effects on fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What Is the Evidence for 5-Amino-1MQ's Mechanism?
Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activates SIRT1 longevity pathways. Also stimulates AMP-activated protein kinase (AMPK) in adipocytes and myocytes, promoting mitochondrial biogenesis and fat oxidation.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for 5-Amino-1MQ?
Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, 5-Amino-1MQ has shown encouraging results.
What Does the Safety Research Show?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
5-Amino-1MQ is not fda-approved. available as research chemical. not scheduled or controlled.
What Makes 5-Amino-1MQ Unique in Research?
First-in-class NNMT inhibitor — the only compound that boosts NAD+ by preventing its precursor from being degraded, rather than simply supplementing more precursor.
This differentiator is important because it means 5-Amino-1MQ fills a role that other compounds in its class may not fully replicate.
Bottom Line on 5-Amino-1MQ Research
The evidence base for 5-Amino-1MQ is growing. Key research areas include fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
Stay current with PubMed searches for 5-Amino-1MQ for the latest publications.
Complete Guide
5-Amino-1MQ : Benefits, Dosage, Side Effects & Research
Related Reading
- 5-Amino-1MQ Dosage Guide
- 5-Amino-1MQ Benefits
- 5-Amino-1MQ Side Effects
- 5-Amino-1MQ Stacking Guide
- 5-Amino-1MQ Cycle Guide
- MOTS-C Complete Guide
Calculate Your 5-Amino-1MQ Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 5-Amino-1MQ.
Open Calculator →Research-Grade Sourcing
If you're going to research 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What is the recommended 5-Amino-1MQ dosage?
Common dosages: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Cycle length: 4-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Is 5-Amino-1MQ safe?
5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.